Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Oncotarget - 11 Oct 2016

Konopka Bozena, Szafron Lukasz Michal, Kwiatkowska Ewa, Podgorska Agnieszka, Zolocinska Aleksandra, Pienkowska-Grela Barbara, Dansonka-Mieszkowska Agnieszka, Balcerak Anna, Lukasik Martyna, Stachurska Anna, Timorek Agnieszka, Spiewankiewicz Beata, El-Bahrawy Mona, Kupryjanczyk Jolanta

Abstract excerpt

The CEBPA gene is known to be mutated or abnormally expressed in several cancers. This is the first study assessing the clinical impact of CEBPA gene status and expression on the ovarian cancer outcome. The CEBPA gene sequence was analyzed in 118 ovarian cancer patients (44 platinum/cyclophosphamide (PC)-treated and 74 taxane/platinum (TP)-treated), both in tumors and blood samples, and in blood from 236 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to CCAAT-Enhancer-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Ovarian Neoplasms

Share to Prognosis

Share to Proportional Hazards Models

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27602952
DOI: 10.18632/oncotarget.11822
PMCID: PMC5341885

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.PMID 27602952Read ↗

A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.Semantic proximity Read ↗

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patientsSemantic proximity Read ↗

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.Semantic proximity Read ↗

Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.Semantic proximity Read ↗

Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.Semantic proximity Read ↗

A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms in ovarian cancer.Semantic proximity Read ↗

Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility.Semantic proximity Read ↗

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.Semantic proximity Read ↗

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.Semantic proximity Read ↗

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patientsSemantic proximity Read ↗

Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.